Radotinib [926037-48-1]

TargetMol Chemicals

Radotinib [926037-48-1]

4

926037-48-1

Chemical

Research Use Only

Radotinib

99.70%

C27H21F3N8O

530.5

Radotinib (IY-5511), and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors

3 years

Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cnccn3)c2)cc(c1)C(F)(F)F

-20°C

12352200